According to TradingView, Pagaya Technologies (PGY) trades at a forward 12-month price-to-sales ratio of 0.89, well below the industry average of 2.59. That makes the stock look cheap on this one measure. But a single ratio is a screening tool, not a verdict, and the same report shows analysts have not lifted their earnings estimates for the company in the past 30 days.
The more useful reading is what sits behind the discount. Pagaya's first-half 2026 revenues rose to $705 million from $616.4 million a year earlier, while operating expenses edged up only to $519.2 million from $512.2 million, per the company figures cited by TradingView. Revenue is growing faster than costs. Whether that arithmetic holds as funding markets tighten is the real question for a long-term investor, not the ratio itself.
For readers weighing individual stocks against a broader plan built around diversified investing, the Pagaya case is a tidy lesson in why valuation screens and fundamentals must be read together.
What does a low price-to-sales ratio actually measure?
The price-to-sales ratio divides what the market will pay for a company by the revenue it generates. Value investors often prefer it to price-to-earnings because sales are harder to manipulate with accounting choices than earnings, as TradingView notes. A forward ratio uses expected sales over the next twelve months, so it embeds a forecast.
Pagaya's 0.89 forward P/S sits below Upstart Holdings at 1.29 and Virtu Financial at 3.22, per the same report. It is also far below the stock's own three-year high. A discount to peers and to its own history can mean the market underprices the business. It can equally mean the market doubts the quality or durability of those sales. The ratio alone cannot settle which explanation applies.
Why does the funding base matter so much for Pagaya?
Pagaya's business depends on raising cash to fund loans originated through its network. That makes its funding pipeline a leading indicator, and here the reported picture is strong. In the second quarter of 2026, the company raised $3.7 billion across six asset-backed securities transactions, its largest quarterly funding volume to date, and added 11 new investors for a total of 174, according to TradingView's account of company disclosures.
Two structural shifts stand out. Pagaya signed its first forward flow agreement with Neuberger Specialty Finance to purchase up to $700 million of auto loans, a structure that commits a buyer in advance rather than deal by deal. And 40% of funding now comes through non-prefunded ABS products alongside forward flow and revolving structures. The company also expanded its ALPF receivables facility from $65 million to $100 million. Broader, more flexible funding improves execution visibility as volume scales across personal loans, auto and point of sale.
Is the profitability trend real, and how durable is it?
The operating record in 2025 and the first half of 2026 shows revenue growth outpacing expense growth, which turned prior losses into positive net income, per TradingView. Core operating expenses fell 6% year over year and reached 31% of fee revenue less production costs, described as a record low. Management noted core operating expenses have been broadly flat for about 18 months while revenues and profits scaled. This connects to our earlier piece, What a 1% Fund Fee Costs Over Thirty Years.
Management's guidance calls for 2026 GAAP net income of $155 million to $180 million and adjusted EBITDA of $460 million to $490 million. These are the company's own projections, attributed as such, not independent verification. A guidance range is a statement of intent, and it should be checked against results as they arrive.
What do growth and analyst estimates say?
The growth story rests on product breadth. The Affiliate Optimizer engine contributed more than $1 billion of network volume in personal loans in the second quarter. Experian Activate has been adopted by key partners, with regional banks targeted in the second half of 2026. Seven new partners joined over the last six months across personal loans, auto and point of sale. In auto, the company uses dynamic offer optimization to structure down payment, APR, loan-to-value and term in real time at the dealer point of sale.
Yet analyst sentiment is flat. The Zacks Consensus Estimate for Pagaya's 2026 and 2027 earnings has been unchanged over the past 30 days, at $3.72 and $4.13 respectively. A stock that has gained 49.1% in six months, against a 4.6% industry rally, while estimates stand still is a stock whose price has moved ahead of the published earnings outlook. Upstart shares fell 9.8% and Virtu rose 22.2% over the same period, per the same report.
What should a long-term investor take from this?
The report itself strikes a measured note: the discounted valuation, expanding funding base, multi-product growth and improving operating leverage provide a foundation for potential long-term upside, but the valuation discount alone may not support a more bullish stance. TradingView's account also flags that funding costs and tighter ABS economics are pressuring results, though its text cuts off before detailing that pressure.
That gap is the honest summary of the evidence. The positives are documented; the risks are named but not quantified in the supplied material. For most readers of stocks, a single-company position like this carries concentration risk that a diversified core, such as the approach described in What Compounding Actually Looks Like in an Index Fund, is designed to offset. Any single-stock holding should be sized with that in mind.
What remains unknown is whether the market's discount reflects a genuine mispricing or a sober judgment on funding-market sensitivity. The next few quarters of funding volumes and expense ratios, reported against the company's own guidance, will do more to answer that than any ratio screen.
This article is general information, not financial advice. Consider your own circumstances or consult a licensed financial professional.
